The Kagoshima consensus on esophageal achalasia

Diseases of the Esophagus

Volumn 25, Issue 4, 2012, Pages 337-348

  Triadafilopoulos, G ^a   Boeckxstaens, G E ^d   Gullo, R ^b   Patti, M G ^b   Pandolfino, J E ^c   Kahrilas, P J ^c   Duranceau, A ^e   Jamieson, G ^f   Zaninotto, G ^g  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

Achalasia; BoTox injection; Heller myotomy; High resolution manometry; Myotomy

Indexed keywords

BOTULINUM TOXIN;

BARIUM ENEMA; ENDOSCOPIC THERAPY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FOOD REGURGITATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; JAPAN; LOWER ESOPHAGUS SPHINCTER; MYOTOMY; PATHOPHYSIOLOGY; PERISTALSIS; PNEUMATIC DILATION; PRIORITY JOURNAL; REVIEW; SWALLOWING; THORAX PAIN; WEIGHT REDUCTION;

BALLOON DILATION; BOTULINUM TOXINS, TYPE A; ESOPHAGEAL ACHALASIA; ESOPHAGECTOMY; ESOPHAGOPLASTY; HUMANS; NEUROMUSCULAR AGENTS;

EID: 84861200397     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01207.x     Document Type: Review

References (54)

1. Patti M G, Gorodner M V, Galvani C etal. Spectrum of esophageal motility disorders: implications for diagnosis and treatment. Arch Surg 2005; 140: 442-8.
2. Boeckxstaens G E. The lower oesophageal sphincter. Neurogastroenterol Motil 2005; 17 (Suppl 1): 13-21.
3. Goldblum J R, Rice T W, Richter J E. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996; 111: 648-54.
4. Facco M, Brun P, Baesso I etal. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008; 103: 1598-609.
5. Boeckxstaens G E. Achalasia: virus-induced euthanasia of neurons? Am J Gastroenterol 2008; 103: 1610-2.
6. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C etal. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002; 47: 15-9.
7. Fisichella P M, Raz D, Palazzo F, Niponmick I, Patti M G. Clinical, radiological, and manometric profile in 145 patients with untreated achalasia. World J Surg 2008; 32: 1974-9.
8. Schima W, Ryan J M, Harisinghani M etal. Radiographic detection of achalasia: diagnostic accuracy of videofluoroscopy. Clin Radiol 1998; 53: 372-5.
9. El-Takli I, O'Brien P, Paterson W G. Clinical diagnosis of achalasia: how reliable is the barium x-ray? Can J Gastroenterol 2006; 20: 335-7.
10. Nehra D, Lord R V, DeMeester T R etal. Physiologic basis for the treatment of epiphrenic diverticulum. Ann Surg 2002; 235: 346-54.
11. Tedesco P, Fisichella P M, Way L W, Patti M G. Cause and treatment of epiphrenic diverticula. Am J Surg 2005; 190: 891-4.
12. Moonka R, Patti M G, Feo C V etal. Clinical presentation and evaluation of malignant pseudo-achalasia. J Gastrointest Surg 1999; 3: 456-61.
13. Liu W, Fackler W, Rice T W, Richter J E, Achkar E, Goldblum J R. The pathogenesis of pseudo-achalasia: a clinico-pathologic study of 13 cases of a rare entity. Am J Surg Pathol 2002; 26: 784-8.
14. Clouse R E, Staiano A. Topography of the esophageal peristaltic pressure wave. Am J Physiol 1991; 261: G677-684.
15. Pandolfino J E, Ghosh S K, Rice J, Clarke J O, Kwiatek M A, Kahrilas P J. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol 2008; 103: 27-37.
16. Pandolfino J E, Kwiatek M A, Nealis T J, Bulsiewicz W, Post J, Kahrilas P J. Achalasia: it's not all one disease. Gastroenterology 2008; 135: 1526-33.
17. Salvador R, Costantini M, Zaninotto G etal. The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. J Gastrointest Surg 2010; 14: 1635-45.
18. Scherer J R, Kwiatek M A, Soper N J, Pandolfino J E, Kahrilas P J. Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. J Gastrointest Surg 2009; 13: 2219-25.
19. Kadakia S C, Wong R K. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol 1993; 88: 34-8.
20. Katz P O, Gilbert J, Castell D O. Pneumatic dilatation is effective long-term treatment for achalasia. Dig Dis Sci 1998; 43: 1973-7.
21. Ghoshal U C, Kumar S, Saraswat V A, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 2004; 99: 2304-10.
22. Eckardt V F, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53: 629-33.
23. Farhoomand K, Connor J T, Richter J E, Achkar E, Vaezi M F. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004; 2: 389-94.
24. Zhu Q, Liu J, Yang C. Clinical study on combined therapy of botulinum toxin Injection and small balloon dilation in patients with esophageal achalasia. Dig Surg 2009; 26: 493-8.
25. Bravi I, Nicita M T, Duca P etal. A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term. Aliment Pharmacol Ther 2010; 31: 658-65.
26. Boeckxstaens G E, Annese V, Bruley des Varannes S etal. The European achalasia trial: a randomized multicenter trial comparing endoscopic pneumodilation and laparoscopic myotomy as primary treatment of idiopathic achalasia. Gastroenterology 2010; 138: S-53.
27. Campos G M, Vittinghoff E, Rabl C etal. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 2009; 249: 45-57.
28. Wang L, Li Y M, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 2009; 54: 2303-11.
29. Inoue H, Minami H, Satodate H, Kudo S-E. First clinical experience of submucosal endoscopic esophageal myotomy for esophageal achalasia with no skin incision. Gastrointest Endosc 2009; 69: AB122.
30. Wang Y R, Dempsey D T, Friedenberg F K, Richter J E. Trends of Heller myotomy hospitalizations for achalasia in the United States, 1993-2005: effect of surgery volume on perioperative outcomes. Am J Gastroenterol 2008; 103: 2454-64.
31. Grotenhuis B A, Wijnhoven B P, Jamieson G G, Devitt P G, Bessell J R, Watson D I. Defining a learning curve for laparoscopic cardiomyotomy. World J Surg 2008; 32: 1689-94.
32. Oelschlager B K, Chang L, Pellegrini C A. Improved outcome after extended gastric myotomy for achalasia. Arch Surg 2003; 138: 490-7.
33. Bessell J R, Lally C J, Schloithe A, Jamieson G G, Devitt P G, Watson D I. Laparoscopic cardiomyotomy for achalasia: long-term outcomes. ANZ J Surg 2006; 76: 558-62.
34. Richards W O, Torquati A, Holzman M D etal. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg 2004; 240: 405-15.
35. Falkenback D, Johansson J, Oberg S etal. Heller's esophagomyotomy with or without a 360 degrees floppy Nissen fundoplication for achalasia. Long-term results from a prospective randomized study. Dis Esophagus 2003; 16: 284-90.
36. Rebecchi F, Giaccone C, Farinella E, Campaci R, Morino M. Randomized controlled trial of laparoscopic Heller myotomy plus Dor fundoplication versus Nissen fundoplication for achalasia: long-term results. Ann Surg 2008; 248: 1023-30.
37. Patti M G, Herbella F A. Fundoplication after laparoscopic Heller myotomy for esophageal achalasia: what type? J Gastrointest Surg 2010; 14: 1453-8.
38. Zaninotto G, Costantini M, Rizzetto C etal. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg 2008; 248: 986-93.
39. Kilic A, Schuchert M J, Pennathur A, Gilbert S, Landreneau R J, Luketich J D. Long-term outcomes of laparoscopic Heller myotomy for achalasia. Surgery 2009; 146: 826-31. discussion 831-3.
40. Chen Z, Bessell J R, Chew A, Watson D I. Laparoscopic cardiomyotomy for achalasia: clinical outcomes beyond 5 years. J Gastrointest Surg 2010; 14: 594-600.
41. Ellis F H Jr, Watkins E Jr, Gibb S P, Heatley G J. Ten to 20 year clinical results after short esophagomyotomy without an antireflux procedure (Modified Heller Operation) for esophagal achalasia. Eur J Cardiothorac Surg 1992; 6: 86-90.
42. Okike N, Payne W S, Neufe D D N, Bernatz P E, Paroleiro P C, Sanderson D R. Esophagomyotomy versus forceful dilatation for achalasia of the esophagus: results in 899 patients. Ann Thorac Surg 1979; 28: 119-25.
43. Vela M, Richter J E, Wachsberger D etal. Complexities of managing achalasia in a tertiary referral center: use of PD, Heller myotomy and Botox. Am J Gastroenterol 2004; 99: 1029-36.
44. Duranceau A, Liberman M, Martin J, Ferraro P. End-stage achalasia. Dis Esophagus 2010; DOI: 10.1111/j.1442-2050.2010.01157.x.
45. Lehman M B, Clark S B, Ormsby A H, Rice T W, Richter J E, Goldblum J R. Squamous mucosal alterations in esophageal specimens from patients with end stage achalasia. Am J Surg Pathol 2001; 25: 1413-18.
46. Streitz J M, Ellis F H, Gibb S P etal. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg 1995; 59: 1604-9.
47. Richter J E. Update of the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol 2008; 2: 435-45.
48. Peters J H, Kauer K H, Crookes P F, Ireland A P, Bremner C G, DeMeester T R. Esophageal resection with colon interposition for end stage achalasia. Arch Surg 1995; 130: 632-7.
49. D'Journo X B, Martin J, Rakovic G, Brigad C. Mucosal damage in the esophageal remnant after esophagectomy and gastric interposition. Ann Surg 2009; 249: 262-8.
50. D'Journo X B, Martin J, Gaboury L, Ferraro P, Duranceau A. Roux-en-Y diversion for intractable reflux after esophagectomy. Ann Thorac Surg 2008; 86: 1646-52.
51. Ellis F H, Crozier R E, Gibb S P. Reoperative achalasia surgery. J Thorac Cardiovasc Surg 1986; 92: 859-65.
52. Jeyasingham K, Lerut T, Belsey R H. Functional and mechanical sequelae of colon interposition for benign oesophageal disease. Eur J Cardiothorac Surg 1999; 15: 327-31.
53. Jeyasingham K, Lerut T, Belsey R H. Revisional surgery after colon interposition for benign esophageal disease. Dis Esophagus 1999; 12: 7-9.
54. Merendino K A, Dilliard D H. The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophago-gastric junction with special references to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg 1955; 142: 486-506.